http://paratekpharma.com
Paratek Pharmaceuticals, Inc. Company Intro
Paratek Pharmaceuticals (NASDAQ: PRTK) is a biopharmaceutical company that develops transformative solutions for patients, both in and out of the hospital, with diseases that are not responsive to current treatments. We focus on drugs that target infectious disease and other difficult to treat conditions.
Industry
Healthcare
Paratek Pharmaceuticals, Inc. Headquaters
75 Park Plaza
Boston,02116
United States
Paratek Pharmaceuticals, Inc. Share price
14 Sep 2022 10:04 GMT
$2.4900
-0.08 (-3.11 %)
Paratek Pharmaceuticals, Inc. Market cap
$120.955 M
WMC RANKING
2023
Paratek Pharmaceuticals, Inc. # 107
BiotechnologyLatest Paratek Pharmaceuticals, Inc. News
27 Jan 2023
Jefferies Financial Group Comments on Paratek ...
Jefferies Financial Group Comments on Paratek Pharmaceuticals, Inc.'s FY2022 Earnings (NASDAQ:PRTK). Fri., January 27, 2023 | MarketBeat.
27 Jan 2023
Jefferies Financial Group Comments on Paratek ...
Jefferies Financial Group Comments on Paratek Pharmaceuticals, Inc.'s FY2022 Earnings (NASDAQ:PRTK). Fri., January 27, 2023 | MarketBeat.
25 Jan 2023
U.S. RESEARCH ROUNDUP-Enphase Energy, VF Corp ...
U.S. RESEARCH ROUNDUP-Enphase Energy, VF Corp, Zions Bancorporation ... price objective $103 * Paratek Pharmaceuticals Inc : Jefferies cuts target price to...
WMC Market Score
WMC Market to Revenue Score
Paratek Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Paratek Pharmaceuticals, Inc. | USD | $55,431 | $111,647 | $-87,270 | $1,210M | 107 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Paratek Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Paratek Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Paratek Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Paratek Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Paratek Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Paratek Pharmaceuticals, Inc. | 0.60 | 8.34 | 0.04 | 0 | 0 | 0 | 3.81 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
